The dual endothelin-1 antagonist aprocitentan alleviates mitochondrial oxidative stress in human cardiac fibroblasts is a research paper published in European Heart Journal - Cardiovascular Pharmacotherapy (2024). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Heart Association
Grant: 24IPA1268813
American Heart Association
Grant: 22POST915561
American Heart Association
Grant: 24POST1195524
American Heart Association
Grant: 21POST836407
American Heart Association
Grant: 23POST1026190
National Heart, Lung, and Blood Institute
Grant: R01-HL146691
National Heart, Lung, and Blood Institute
Grant: T32-HL144456
National Heart, Lung, and Blood Institute
Grant: T32-HL172255
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01-DK033823
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01-DK123259
NHLBI NIH HHS
Grant: R01 HL146691
NHLBI NIH HHS
Grant: T32 HL144456
NIDDK NIH HHS
Grant: R01 DK033823
NHLBI NIH HHS
Grant: T32 HL172255
NIDDK NIH HHS
Grant: R01 DK123259
NIH HHS
National Institutes of Health
Fields of Study
MeSH Terms